We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PATI
1376
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$5.71M ﹤0.01%
293,629
JMP
1377
DELISTED
JMP Group LLC
JMP
$5.7M ﹤0.01%
1,050,112
+67,500
+7% +$357K
MSEX icon
1378
Middlesex Water
MSEX
$1.11B
$5.68M ﹤0.01%
+130,840
New +$4.84M
TTI icon
1379
TETRA Technologies
TTI
$1.25B
$5.68M ﹤0.01%
891,060
-1,273,120
-59% -$7.85M
EXP icon
1380
Eagle Materials
EXP
$6.41B
$5.65M ﹤0.01%
73,225
-16,650
-19% -$1.26M
RGEN icon
1381
Repligen
RGEN
$9.45B
$5.59M ﹤0.01%
204,390
+12,400
+6% +$317K
SLAB icon
1382
Silicon Laboratories
SLAB
$7.28B
$5.55M ﹤0.01%
113,844
-587,006
-84% -$27.7M
KS
1383
DELISTED
KapStone Paper and Pack Corp.
KS
$5.52M ﹤0.01%
424,520
+10,600
+3% +$155K
MDSO
1384
DELISTED
Medidata Solutions, Inc.
MDSO
$5.51M ﹤0.01%
117,650
+710
+0.6% +$30.9K
HONE
1385
DELISTED
HarborOne Bancorp
HONE
$5.49M ﹤0.01%
+762,516
New +$5.49M
BRK.A icon
1386
Berkshire Hathaway Class A
BRK.A
$1.09T
$5.42M ﹤0.01%
25
RCKT icon
1387
Rocket Pharmaceuticals
RCKT
$367M
$5.42M ﹤0.01%
182,108
-125
-0.1% -$4.39K
SNMX
1388
DELISTED
Senomyx, Inc.
SNMX
$5.4M ﹤0.01%
1,962,255
+2,500
+0.1% +$6.71K
OI icon
1389
O-I Glass
OI
$1.05B
$5.39M ﹤0.01%
299,030
+22,000
+8% +$404K
TTM
1390
DELISTED
Tata Motors Limited
TTM
$5.32M ﹤0.01%
153,296
-15,536
-9% -$486K
INFO
1391
DELISTED
IHS Markit Ltd. Common Shares
INFO
$5.31M ﹤0.01%
162,800
-4,100
-2% -$139K
OIS icon
1392
Oil States International
OIS
$526M
$5.28M ﹤0.01%
160,680
-2,300
-1% -$74.5K
GHM icon
1393
Graham Corp
GHM
$1.3B
$5.27M ﹤0.01%
286,200
+28,734
+11% +$530K
PLCM
1394
DELISTED
POLYCOM INC
PLCM
$5.12M ﹤0.01%
454,674
-37,600
-8% -$439K
CPA icon
1395
Copa Holdings
CPA
$6.17B
$4.98M ﹤0.01%
95,268
+100
+0.1% +$5.77K
NAUH
1396
DELISTED
National American University Holdings, Inc.
NAUH
$4.86M ﹤0.01%
2,456,503
WLH
1397
DELISTED
WILLIAM LYON HOMES
WLH
$4.85M ﹤0.01%
301,090
-340,925
-53% -$5.21M
FBR
1398
DELISTED
Fibria Celulose Sa
FBR
$4.8M ﹤0.01%
710,600
+70,700
+11% +$602K
TBPH icon
1399
Theravance Biopharma
TBPH
$878M
$4.78M ﹤0.01%
210,763
+87,200
+71% +$1.88M
SEMG
1400
DELISTED
SEMGROUP CORPORATION
SEMG
$4.55M ﹤0.01%
139,610
-45,500
-25% -$1.32M

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.